Search for: "Merck and Co," Results 161 - 180 of 1,276
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jun 2018, 11:55 pm by admin
Merck and Co., Inc., 110 Nev. 762, 878 P.2d 948 (1994) (Public policy demands that the burden of accidental injuries caused by products intended for consumption be placed upon those that market them and be treated as a cost of production against which liability insurance can be obtained). [read post]
7 May 2018, 4:15 am by Steve Brachmann
Merck & Co. et. al., which affirmed a lower court’s ruling that Merck could not assert claims from two patents against Gilead because Merck had unclean hands regarding the patents. [read post]
7 May 2018, 4:15 am by Steve Brachmann
Merck & Co. et. al., which affirmed a lower court’s ruling that Merck could not assert claims from two patents against Gilead because Merck had unclean hands regarding the patents. [read post]
30 Apr 2018, 2:31 pm by Eugene Volokh
But Phillips and McCauley had a falling-out, and Phillips started posting allegations that McCauley was actually soft on the anti-vaccination movement and was actually "shillin for Merck"; part of his rhetoric was that anti-vaccination people had to save Ella from McCauley, who wasn't adequately protecting her from the evils of vaccines. [read post]
26 Apr 2018, 7:47 am
 In the field of pharmaceuticals, notable inventors include Rachel Fuller Brown and Elizabeth Lee Hazen, co-inventors of the first anti-fungal Nystatin (Mycostatin). [read post]
25 Apr 2018, 12:08 pm by Dennis Crouch
   In the 1933 case of Keystone Driller Co. v. [read post]
17 Mar 2018, 7:18 am by Howard Bashman
“Massachusetts court: Merck can be sued over generic drug injury. [read post]
14 Feb 2018, 2:57 pm by Kevin LaCroix
CalPERS appealed, asserting that its individual suit was timely because the three-year time limit was subject to equitable tolling pursuant to American Pipe & Construction Co. v. [read post]
3 Feb 2018, 8:58 pm by Patent Docs
Jorge Goldstein of Sterne, Kessler, Goldstein & Fox, PLLC; Brian Kacedon of Finnegan, Henderson, Farabow, Garrett & Dunner LLP; and William Krovatin of Merck & Co Inc. will discuss strategies and recent court cases that involve: • Staking out the claim that a sale is not an "authorized sale" — Chrimar v. [read post]